https://clinicaltrials.gov/ct2/show/NCT03093402?type=Intr&cond=Lupus&phase=012345&lupd_s=01%2F04%2F2019&lupd_d=14
Conditions : Systemic Lupus Erythematosus; SLE; Lupus
Interventions : Drug: JBT-101; Drug: Placebo
Sponsors : National Institute of Allergy and Infectious Diseases (NIAID); Corbus Pharmaceuticals Inc.; Autoimmunity Centers of Excellence
Recruiting
JBT-101 in Systemic Lupus Erythematosus (SLE)
NCT03093402
Tue, 28 Mar 2017 12:00:00 EDT
